Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Boardman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nursing Management|May 29, 2003
Shining through a mergerKaren Boardman, Maureen Kelpe, Dawn Straub, et al.
American Journal of Surgery|May 30, 2002
Perspective on reconstruction after mastectomyCarmen Baker, Nathalie Johnson, Joanne Nelson, et al.
Trials|March 9, 2018
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trialAlina Striha, A John Ashcroft, Anna Hockaday, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nursing Management|May 29, 2003
Shining through a mergerKaren Boardman, Maureen Kelpe, Dawn Straub, et al.
American Journal of Surgery|May 30, 2002
Perspective on reconstruction after mastectomyCarmen Baker, Nathalie Johnson, Joanne Nelson, et al.
Trials|March 9, 2018
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trialAlina Striha, A John Ashcroft, Anna Hockaday, et al.
Pageof 1